These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31004286)

  • 41. Relief of cough and nasal symptoms associated with allergic rhinitis by mometasone furoate nasal spray.
    Gawchik S; Goldstein S; Prenner B; John A
    Ann Allergy Asthma Immunol; 2003 Apr; 90(4):416-21. PubMed ID: 12722964
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study.
    Heppner DG; Kemp TL; Martin BK; Ramsey WJ; Nichols R; Dasen EJ; Link CJ; Das R; Xu ZJ; Sheldon EA; Nowak TA; Monath TP;
    Lancet Infect Dis; 2017 Aug; 17(8):854-866. PubMed ID: 28606591
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A double-blind, placebo-controlled study of the safety and efficacy of ipratropium bromide nasal spray versus placebo in patients with the common cold.
    Dockhorn R; Grossman J; Posner M; Zinny M; Tinkleman D
    J Allergy Clin Immunol; 1992 Dec; 90(6 Pt 2):1076-82. PubMed ID: 1460211
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the efficacy and safety of two eye gels in the treatment of dry eyes: Lacrinorm and Viscotears.
    Bron AJ; Daubas P; Siou-Mermet R; Trinquand C
    Eye (Lond); 1998; 12 ( Pt 5)():839-47. PubMed ID: 10070521
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold.
    Fazekas T; Eickhoff P; Pruckner N; Vollnhofer G; Fischmeister G; Diakos C; Rauch M; Verdianz M; Zoubek A; Gadner H; Lion T
    BMC Complement Altern Med; 2012 Sep; 12():147. PubMed ID: 22950667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Double-blind trials of azelastine nasal spray monotherapy versus combination therapy with loratadine tablets and beclomethasone nasal spray in patients with seasonal allergic rhinitis. Rhinitis Study Groups.
    Berger WE; Fineman SM; Lieberman P; Miles RM
    Ann Allergy Asthma Immunol; 1999 Jun; 82(6):535-41. PubMed ID: 10400480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metoclopramide Nasal Spray Reduces Symptoms of Gastroparesis in Women, but not Men, With Diabetes: Results of a Phase 2B Randomized Study.
    Parkman HP; Carlson MR; Gonyer D
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1256-1263.e1. PubMed ID: 25576687
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered
    Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J
    Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intranasally and orally administered antihistamine treatment of experimental rhinovirus colds.
    Gaffey MJ; Gwaltney JM; Sastre A; Dressler WE; Sorrentino JV; Hayden FG
    Am Rev Respir Dis; 1987 Sep; 136(3):556-60. PubMed ID: 3307567
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.
    Spangler DL; Abelson MB; Ober A; Gotnes PJ
    Clin Ther; 2003 Aug; 25(8):2245-67. PubMed ID: 14512132
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC; Fiske K; Lyne A
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Echinacea purpurea therapy for the treatment of the common cold: a randomized, double-blind, placebo-controlled clinical trial.
    Yale SH; Liu K
    Arch Intern Med; 2004 Jun; 164(11):1237-41. PubMed ID: 15197051
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.
    Gawel M; Aschoff J; May A; Charlesworth BR;
    Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in patients with allergy to Texas mountain cedar pollen.
    Howland WC; Amar NJ; Wheeler W; Sacks H
    Int Forum Allergy Rhinol; 2011; 1(4):275-9. PubMed ID: 22287431
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Zinc gluconate lozenges for treating the common cold in children: a randomized controlled trial.
    Macknin ML; Piedmonte M; Calendine C; Janosky J; Wald E
    JAMA; 1998 Jun; 279(24):1962-7. PubMed ID: 9643859
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
    Ratner PH; Hampel F; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):74-81. PubMed ID: 18254486
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Azelastine nasal spray as adjunctive therapy to azelastine tablets in the management of seasonal allergic rhinitis.
    Weiler JM; Meltzer EO
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):327-32. PubMed ID: 9357378
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis.
    Banov CH; Lieberman P;
    Ann Allergy Asthma Immunol; 2001 Jan; 86(1):28-35. PubMed ID: 11206234
    [TBL] [Abstract][Full Text] [Related]  

  • 59. OTC use of a topical nasal spray solution containing xylometazoline plus ipratropium in patients with common cold.
    Strandell B; Norgren-Holst E; Tran N; Jakobsen HB; Chen S
    Int J Clin Pharmacol Ther; 2009 Dec; 47(12):744-51. PubMed ID: 19954713
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intranasally administered atropine methonitrate treatment of experimental rhinovirus colds.
    Gaffey MJ; Gwaltney JM; Dressler WE; Sorrentino JV; Hayden FG
    Am Rev Respir Dis; 1987 Jan; 135(1):241-4. PubMed ID: 3800150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.